When primaquine radical cure is included in national guidelines, it is usually prescribed without prior testing for glucose-6-phosphate dehydrogenase (G6PD) deficiency. The gene discussed is G6PD; the disease is hyperinsulinemic hypoglycemia, familial, 4.